Tumor regression grading after neoadjuvant treatment of esophageal and gastroesophageal junction adenocarcinoma: results of an international Delphi consensus survey.

Human Pathology
G SalibaF Klevebro

Abstract

Complete histopathologic tumor regression after neoadjuvant treatment is a well-known prognostic factor for survival among patients with adenocarcinomas of the esophagus and gastroesophageal junction. The aim of this international Delphi survey was to reach a consensus regarding the most useful tumor regression grading (TRG) system that could represent an international standard for histopathologic TRG grading of gastroesophageal carcinomas. Fifteen pathologists with special interest in esophageal and gastric pathology participated in the online survey. The initial questionnaire contained of 43 statements that addressed the following topics: (1) specimen processing, (2) gross examination, (3) cross sectioning, (4) staining, (5) Barrett's esophagus, (6) TRG systems, and (7) TRG in lymph node (LN). Participants rated the items using a 5-point Likert style scale and were encouraged to write comments for each statement. The expert panel recommended a 4-tiered TRG system for assessing the primary tumor: grade 1: No residual tumor (complete histopathologic tumor regression), grade 2: less than 10% residual tumor (near-complete regression), grade 3: 10%-50% residual tumor (partial regression), grade 4: greater than 50% residual tumor (...Continue Reading

References

Jan 6, 2000·Journal of Health Services Research & Policy·N BlackT Marteau
Feb 13, 2003·Journal of Advanced Nursing·Catherine Powell
Sep 23, 2003·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Jessica S DoningtonPeter C Pairolero
Mar 3, 2007·The Lancet Oncology·Val GebskiUNKNOWN Australasian Gastro-Intestinal Trials Group
Jul 30, 2008·Annals of Surgical Oncology·Andrew P BarbourB Mark Smithers
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Sep 12, 2013·Annals of Surgery·Ashleigh M FrancisUNKNOWN University of Texas MD Anderson Esophageal Cancer Group
Oct 14, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Arnulf H HölscherJakob R Izbicki
Nov 8, 2014·Annals of Surgery·Arnulf H HölscherEfriede Bollschweiler
Jan 20, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F KlevebroM Nilsson
Mar 30, 2017·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·G TomaselloS Barni
Mar 7, 2020·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·F KlevebroS Detlefsen

❮ Previous
Next ❯

Citations

Jun 25, 2021·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·Michael Vieth, Markus F Neurath

❮ Previous
Next ❯

Related Concepts

Related Feeds

Barrett Esophagus

Barrett’s esophagus if a serious complication of gastroesophageal reflux disease during which the normal esophageal lining changes to tissue that resembles intestinal lining. Here is the latest research.